Login
Companies $XGN
$3.80 +$0.03 (0.8%) After hours
EXAGEN INC. logo

EXAGEN INC.

exagen.com

What Do They Do?

Sells AVISE blood tests that help rheumatologists, primary care physicians and other specialists diagnose and monitor autoimmune and rheumatic diseases.

How Do They Make Money?

Clinicians order tests, while insurers, government programs, hospitals and other laboratories, and patients pay. Exagen bills for each test, with collections generally coming 30 to 90 days after billing.

FY2025 revenue

Who Are Their Customers?

Exagen markets tests to rheumatologists and physician assistants through its specialized sales force; these clinicians order tests for patients. Insurers, government programs, hospitals and other laboratories, and patients pay for them.

Do Revenues Turn Into Profits?

No. It lost $20M in FY2025.

Operating income, FY2025
−21% of revenue
▼ −3% (Loss) vs FY2024 (−$13.6M, −25%)
Net income, FY2025
−30% of revenue
▼ −32% (Loss) vs FY2024 (−$15.1M, −27%)
Free cash flow, FY2025
−21% of revenue
▼ −3% (Loss) vs FY2024 (−$13.8M, −25%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +7%
vs $17.2M in Q3 FY2025
Net income
▲ +11% (Loss)
vs −$7.1M in Q3 FY2025
  • Nov 10, 2026 Reiterated full-year 2026 revenue guidance The company reiterated guidance of $72 million to $75 million in revenue for the year.

Growing. Revenue grew 38% in 4 years, from $48.3M in FY2021 to $66.6M in FY2025, about 8% a year.

Expanded AVISE CTD panel The earlier report described AVISE CTD as a broad test for connective-tissue diseases; the latest says its panel added biomarkers used to diagnose lupus and rheumatoid arthritis.

Who Do They Compete With?

Competes with ARUP Laboratories, Laboratory Corporation of America Holdings, Mayo Clinic, Quest Diagnostics, Aqtual, AMPEL BioSolutions, DxTerity Diagnostics, Genalyte, Immunovia, Oncimmune Holdings, and Progentec Diagnostics

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support